Kenney Christopher John insider trades
Kenney Christopher John has filed 11 Form 4s with the SEC that we hold, all for Xenon Pharmaceuticals Inc. (XENE), as Chief Medical Officer. Across all of them we count 1 purchase worth $20.2K and 5 sales worth $694.8K reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($670.3K). The largest single trade was a sale of 6,368 shares of Xenon Pharmaceuticals Inc. worth $383.1K, dated 2026-08-28. Of 2 sales filed since we began reading the 10b5-1 checkbox, 2 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-08-25 and the latest 2026-08-31.
Xenon Pharmaceuticals Inc. (XENE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-01-21 | P, purchase reported on Form 4 | 700 | $20.2K | 2022-01-21 |
| 2023-03-24 | S, sale reported on Form 4 | 700 | $24.5K | 2023-03-24 |
| 2026-03-10 | S, sale reported on Form 4 | 2,771 | $166.6K | 2026-03-11 |
| 2026-03-13 | S, sale reported on Form 4 | 1,410 | $77.9K | 2026-03-13 |
| 2026-08-28 | S, sale reported on Form 4 | 6,368 | $383.1K | 2026-08-31 |
| 2026-08-28 | S, sale reported on Form 4 | 700 | $42.7K | 2026-08-31 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1880129) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms